SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021

New York, New York – (Newsfile Corp. – June 24, 2021) – The Gross Law Firm, a securities litigation firm, announces on behalf of the shareholders of Ocugen, Inc.

Shareholders who have acquired shares in OCGN during the listed equity period are encouraged to contact the company regarding a possible appointment as lead plaintiff. The appointment as lead plaintiff is not required to participate in a recovery.


Ocugen, Inc. Loss Submission Form

CLASS PERIOD: February 2, 2021 to June 10, 2021

ALLEGES: The complaint alleges that during the classroom, Defendants made materially false and / or misleading statements and / or failed to disclose: (i) the information submitted to the US Food and Drug Administration (“FDA”) were insufficient to obtain an Emergency Authorization (“EUA”), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company’s financial statements and Defendants’ statements about Ocugen’s business, operations, and Prospects that were false, misleading and / or had no sound basis.

The law firm Gross is committed to ensuring that companies adhere to responsible business practices and practice good corporate citizenship. The Company seeks redress on behalf of investors who have suffered losses when false and / or misleading information or the failure of a company to provide material information results in artificial inflation of the Company’s shares. Lawyer advertising. Previous results do not guarantee similar results.

The big law firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770

To view the source version of this press release, please visit

Comments are closed.